Regeneron’s Oncology Strategy Gets Warmer With Early Prostate Data

Company Posts Solid Q2 Sales Despite REGEN-COV Drop

 
• By Alaric DeArment
  
Regeneron reported its Q2 earnings and early data from a bispecific antibody trial • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business